TCL Archive Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality September 18, 1987
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014